EMA Authorised: Azomyr (desloratadine) — Organon N.V.

View source ↗

Summary

The European Medicines Agency authorised Azomyr, a desloratadine-containing medicine by Organon N.V., for allergic rhinitis (seasonal and perennial) and urticar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis
• Urticaria

Drugs mentioned

• Azomyr (desloratadine)

Snippet

Status: Authorised. Therapeutic area: Rhinitis, Allergic, Perennial;Urticaria;Rhinitis, Allergic, Seasonal. MAH: Organon N.V.. Decision date: 26/02/2026